ATANIS Biotech AG
Entity

  • ATANIS Biotech AG

    Created in 2021
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    2,848

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Hubelmatte 26, 6208 Oberkirch, Switzerland

    Oberkirch

    Switzerland

  • Employees

    Scale: 2-10

    Estimated: 11

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    10 months, 4 weeks ago
Description
  • Value proposition

    We revolutionize allergy diagnosis

    ATANIS Biotech AG has been incorporated as a spin-off company from the University of Bern by the four co-founders Mrs. Noemi Zbären, Prof. Thomas Kaufmann, Prof. Alexander Eggel and Prof. Jean-Pierre Kinet in Summer 2021. The company has developed a novel functional cell based assay that massively simplifies the diagnosis of allergies and can predict treatment success of therapies. This test will additionally be used to assess safety and efficacy of potential new drug candidates for allergy treatment as well as for the evaluation of allergenicity of various food products. The proprietary assay is offered through a fee-for-service business model to our customers all over the world.

    Contact us at: info@atanis-biotech.com

    Allergy, Diagnostics, In vitro testing, Fee for service, Pre-clinical assessments, Clinical Trials, Food Products, and Allergenicity

  • ATANIS Biotech

    At ATANIS Biotech AG, our mission is to revolutionize the way allergies are diagnosed and thereby to improve treatment success.

    • https://www.atanis-biotech.com/
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics